Skip to content

The study of relationship between spontaneous echo contrast on esophageal ultrasound and cognitive function in patients with atrial fibrillation: a multicenter, prospective, observational cohort study

The study of relationship between spontaneous echo contrast on esophageal ultrasound and cognitive function in patients with atrial fibrillation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080444
Enrollment
Unknown
Registered
2024-01-29
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial ffibrillation

Interventions

Different levels of spontaneous echo contrast under esophageal ultrasound:None

Sponsors

Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ? Age =18 years old; ? Patients with atrial fibrillation undergoing esophageal ultrasonography; ? Basic language, reading and writing, drawing, calculation and logical thinking skills.

Exclusion criteria

Exclusion criteria: ?The following diagnoses are included: valve disease of the heart, congenital heart disease, rheumatic heart disease, cardiomyopathy (dilated/hypertrophic), any history of cardiac surgery and/or valve replacement, hyperthyroidism; ? First diagnosis or history of chronic kidney failure (glomerular filtration rate <60ml/min/1.73m2); ?Diagnosed malignant tumors, hematological diseases, autoimmune diseases, infectious diseases, and advanced liver disease; ?Confirmed diagnosis of Alzheimer's disease, vascular dementia, Parkinson's disease, brain tumors, brain trauma, active epilepsy, severe depression, alcohol or drug dependency that can affect cognitive function; ?Within the last 3 months there is a history of stroke; ?Communication difficulties or auditory and visual impairments may affect the cognitive function test results. ?Refusal to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
New onset cognitive dysfunction;spontaneous echo contrast;physical examination;

Secondary

MeasureTime frame
Ultrasound examination of heart, carotid artery, limbs and abdomen;Electrocardiogram (including bedside electrocardiogram and holter electrocardiogram);Results of laboratory tests;

Countries

China

Contacts

Public ContactWang Yuegang

Nanfang Hospital, Southern Medical University

wyg06@fimmu.com+86 137 2526 5686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026